Blog
Uncategorized
15

Psychiatrist Contends Field is ‘Committing Professional Suicide’

It’s not often you hear one of psychiatry’s own speak out so vehemently against the establishment’s ‘dangerously close’ relationship with the pharmaceutical industry.  But, that’s exactly what Dr. David Healy, a psychiatrist from Ireland, does. In a Time Healthland article published this week, Dr Healy, “likened psychiatry’s attitude toward its faltering …

Read More
Abilify
94

Is There Now Evidence Withdrawal From Antipsychotics Can Induce Psychosis?

For those who aren’t regular readers of my blog, I have been struggling to quit Abilify – a powerful antipsychotic medication – without success.  This has been a frightening, long and drawn out process for me, since the withdrawal symptoms I’ve experienced every time I have tried to quit this …

Read More
Uncategorized
5

Extended Vacation

I started writing a bang-up post with every intention of publishing before I departed for three whole weeks of vacation. I just didn’t get around to finishing it.  But, I’m going on vacation anyway.  🙂 Manic Muses will be on a posting (and reading) hiatus until the end of September. I …

Read More
Abilify
30

Abilify Withdrawal – Round 3: Abilify Wins and Antipsychotic Dependence

Abilify wins. I put up a tough fight, but in the end, with serious commitments looming, I decided to surrender and let Abilify have this match. Titering down very slowly and using the every-other-day method really did work. I was down to 2.5mg every other day and had great results …

Read More
Uncategorized

Bipolar drug sales slide: more patients but more generics

The drug companies aren’t very happy, and we Bipolar patients shouldn’t be either. According to an article in PharmaTimes, there are more atypical antipsychotics going generic, enough for a monetary, ‘precipitous decline’ to be felt within the drug class (although the article did not detail which drugs or when).   …

Read More
Uncategorized
3

Antiepileptic Drugs Are the Most Commonly Prescribed Drug Class Among Newly Diagnosed Bipolar Disorder Patients in the United States

As a Bipolar I sufferer, I have been on the anti-seizure medication Trileptal (Oxcarbazepine) for over a year and have spectacular mood stabilization results to report.  http://www.marketwatch.com/story/antiepileptic-drugs-are-the-most-commonly-prescribed-drug-class-among-newly-diagnosed-bipolar-disorder-patients-in-the-united-states-2012-08-02

Read More
Uncategorized

What Does a Killer Think?

Using Aurora as a backdrop, this outstanding article in The Daily Beast seeks to help the lay person understand the differences between psychopaths, the delusionally insane and the suicidally depressed as the diagnoses relate to mass murderers. What Does a Killer Think?

Read More
Abilify
2

Abilify Withdrawal – Round 2

Vivien-1, Abilify-1. Here’s a brief update for all those interested in the trials and tribulations of attempting to quit Abilify.  (Round 1 was documented here.) The alternating-days-with-a high-and-then-a low-dose-to-titer-down approach is working its magic.  The lowering from 7.5mg to 5mg phase was successfully completed with no further orientation issues.  Balance …

Read More
Uncategorized

Breaking Down GSK’s Billion Dollar Wrongdoing

http://healthland.time.com/2012/07/05/breaking-down-glaxosmithklines-billion-dollar-wrongdoing/http://healthland.time.com/2012/07/05/breaking-down-glaxosmithklines-billion-dollar-wrongdoing/

Read More
Abilify
12

Another Psychiatric Med Debacle: Glaxo Agrees to Pay $3 Billion in Fraud Settlement

Here we go again. In the largest settlement involving a pharmaceutical company, the British drugmaker GlaxoSmithKline agreed to plead guilty to criminal charges and pay $3 billion in fines for promoting its best-selling antidepressants [Paxil, Wellbutrin, Avandia] for unapproved uses and failing to report safety data about a top diabetes …

Read More
error: Content is protected !!